Renier J Brentjens

16PUBLICATIONS
126CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2026
Interleukin-18 armours antitumour immune effectors.

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Feb 02, 2026
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.

Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe

|Feb 05, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.

Sanam Shahid, Susan E Prockop, Georgia C Flynn

|Jul 03, 2024
Augmenting CAR T-cell Functions with LIGHT.

Winson Cai, Kento Tanaka, Xiaoli Mi

|Jul 03, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.

Jae H Park, Karthik Nath, Sean M Devlin

Pageof 3

Frequent Collaborators

4 joint publications

Michel Sadelain

4 joint publications

Miguel-Angel Perales

4 joint publications

Jae H Park

3 joint publications

Maria Lia Palomba